NCT06838416View on ClinicalTrials.gov

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Type 2 Diabetes MellitusChronic Kidney DiseaseRenal Function
Interventions
DRUG

Finerenone

Treatment will continue for 48 weeks.

Trial Locations (1)

Unknown

RECRUITING

The Second Affiliated Hospital of Suzhou University, Suzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Soochow University

OTHER